Home

varm Tochi träd Gris disulfiram cancer nature Bedövningsmedel Tomhet han

Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4  | Nature
Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4 | Nature

Pharmaceutics | Free Full-Text | Advancing Cancer Therapy with Copper/ Disulfiram Nanomedicines and Drug Delivery Systems
Pharmaceutics | Free Full-Text | Advancing Cancer Therapy with Copper/ Disulfiram Nanomedicines and Drug Delivery Systems

Disulfiram modulated ROS–MAPK and NFκB pathways and targeted breast cancer  cells with cancer stem cell-like properties | British Journal of Cancer
Disulfiram modulated ROS–MAPK and NFκB pathways and targeted breast cancer cells with cancer stem cell-like properties | British Journal of Cancer

Disulfiram-loaded lactoferrin nanoparticles for treating inflammatory  diseases | Acta Pharmacologica Sinica
Disulfiram-loaded lactoferrin nanoparticles for treating inflammatory diseases | Acta Pharmacologica Sinica

Disulfiram modulates ROS accumulation and overcomes synergistically  cisplatin resistance in breast cancer cell lines - ScienceDirect
Disulfiram modulates ROS accumulation and overcomes synergistically cisplatin resistance in breast cancer cell lines - ScienceDirect

Targeting FROUNT with disulfiram suppresses macrophage accumulation and its  tumor-promoting properties | Nature Communications
Targeting FROUNT with disulfiram suppresses macrophage accumulation and its tumor-promoting properties | Nature Communications

Anti-alcohol abuse drug disulfiram inhibits human PHGDH via disruption of  its active tetrameric form through a specific cysteine oxidation |  Scientific Reports
Anti-alcohol abuse drug disulfiram inhibits human PHGDH via disruption of its active tetrameric form through a specific cysteine oxidation | Scientific Reports

Co-delivery of a tumor microenvironment-responsive disulfiram prodrug and  CuO2 nanoparticles for efficient cancer treatment - Nanoscale Advances (RSC  Publishing)
Co-delivery of a tumor microenvironment-responsive disulfiram prodrug and CuO2 nanoparticles for efficient cancer treatment - Nanoscale Advances (RSC Publishing)

Repurposing disulfiram, an alcohol-abuse drug, in neuroblastoma causes  KAT2A downregulation and in vivo activity with a water/oil emulsion |  Scientific Reports
Repurposing disulfiram, an alcohol-abuse drug, in neuroblastoma causes KAT2A downregulation and in vivo activity with a water/oil emulsion | Scientific Reports

Cancers | Free Full-Text | Disulfiram/Copper Induces Immunogenic Cell Death  and Enhances CD47 Blockade in Hepatocellular Carcinoma
Cancers | Free Full-Text | Disulfiram/Copper Induces Immunogenic Cell Death and Enhances CD47 Blockade in Hepatocellular Carcinoma

Frontiers | The Disulfiram/Copper Complex Induces Autophagic Cell Death in  Colorectal Cancer by Targeting ULK1
Frontiers | The Disulfiram/Copper Complex Induces Autophagic Cell Death in Colorectal Cancer by Targeting ULK1

Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor  NPL4. - Abstract - Europe PMC
Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4. - Abstract - Europe PMC

Alcohol-abuse drug disulfiram targets pediatric glioma via MLL degradation  | Cell Death & Disease
Alcohol-abuse drug disulfiram targets pediatric glioma via MLL degradation | Cell Death & Disease

Cytotoxic effect of disulfiram/copper on human cervical cancer cell lines  and LGR5-positive cancer stem-like cells | BMC Cancer | Full Text
Cytotoxic effect of disulfiram/copper on human cervical cancer cell lines and LGR5-positive cancer stem-like cells | BMC Cancer | Full Text

Pharmaceutics | Free Full-Text | Advancing Cancer Therapy with Copper/ Disulfiram Nanomedicines and Drug Delivery Systems
Pharmaceutics | Free Full-Text | Advancing Cancer Therapy with Copper/ Disulfiram Nanomedicines and Drug Delivery Systems

Systematic chemical screening identifies disulfiram as a repurposed drug  that enhances sensitivity to cisplatin in bladder cancer: a summary of  preclinical studies | British Journal of Cancer
Systematic chemical screening identifies disulfiram as a repurposed drug that enhances sensitivity to cisplatin in bladder cancer: a summary of preclinical studies | British Journal of Cancer

Double trouble: A drug for alcoholism can also treat cancer by targeting  macrophages | Tokyo University of Science
Double trouble: A drug for alcoholism can also treat cancer by targeting macrophages | Tokyo University of Science

Cytotoxic effect of disulfiram/copper on human glioblastoma cell lines and  ALDH-positive cancer-stem-like cells | British Journal of Cancer
Cytotoxic effect of disulfiram/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells | British Journal of Cancer

Disulfiram and BKM120 in Combination with Chemotherapy Impede Tumor  Progression and Delay Tumor Recurrence in Tumor Initiating Cell-Rich TNBC |  Scientific Reports
Disulfiram and BKM120 in Combination with Chemotherapy Impede Tumor Progression and Delay Tumor Recurrence in Tumor Initiating Cell-Rich TNBC | Scientific Reports

Targeting FROUNT with disulfiram suppresses macrophage accumulation and its  tumor-promoting properties | Nature Communications
Targeting FROUNT with disulfiram suppresses macrophage accumulation and its tumor-promoting properties | Nature Communications

Repurposing disulfiram, an alcohol-abuse drug, in neuroblastoma causes  KAT2A downregulation and in vivo activity with a water/oil emulsion |  Scientific Reports
Repurposing disulfiram, an alcohol-abuse drug, in neuroblastoma causes KAT2A downregulation and in vivo activity with a water/oil emulsion | Scientific Reports

Disulfiram delays tumor relapse associated with acquired drug... | Download  Scientific Diagram
Disulfiram delays tumor relapse associated with acquired drug... | Download Scientific Diagram

Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4  | Nature
Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4 | Nature

Disulfiram targets cancer stem-like cells and reverses resistance and  cross-resistance in acquired paclitaxel-resistant triple-negative breast  cancer cells | British Journal of Cancer
Disulfiram targets cancer stem-like cells and reverses resistance and cross-resistance in acquired paclitaxel-resistant triple-negative breast cancer cells | British Journal of Cancer

Frontiers | Recent Advances in Repurposing Disulfiram and Disulfiram  Derivatives as Copper-Dependent Anticancer Agents
Frontiers | Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents